Therapeutic indications of incretin-related derivatives and other oral hypoglycemic agents
Katsuno, T.; Miyagawa, J.-I.
Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 3): 693-698
2012
ISSN/ISBN: 0047-1852 PMID: 22768600 Document Number: 658868
Document emailed within 1 workday
Related Documents
Vázquez, A.; Moya, G.; Ricoy, J.R. 1970: Neurological aspects of hypoglycemic coma; hypoglycemic comas of medical origin caused by hypoglycemic agents Revista Clinica Espanola 117(2): 157-168Qian, R. 1997: Proper use of oral hypoglycemic agents Zhonghua Nei Ke Za Zhi 36(3): 149-150
Otto-Buczkowska, E. 1973: Use of oral hypoglycemic agents in diabetic children Polski Tygodnik Lekarski 28(24): 904-907
Skillman, T.G. 1973: Present status of the oral hypoglycemic agents South Dakota Journal of Medicine 26(2): 25-29
Davidoff, F. 1973: Oral hypoglycemic agents: the pharmacological basis of their clinical use Rhode Island Medical Journal 56(10): 409-414
Grujić, M.; Perinović, M.; Rizvanbegović, B. 1976: Oral therapy of diabetes mellitus by combination of hypoglycemic agents Medicinski Arhiv 30(3): 167-171
Tattersall, R.B. 1984: 25 years of diabetic treatment by oral hypoglycemic agents: successes and failures Journees annuelles de diabetologie de l'Hotel-Dieu 1984: 183-191
Pollock, S.H.; Reichbaum, M.I.; Collier, B.H.; D'Souza, M.J. 1991: Inhibitory effect of cyclosporine A on the activity of oral hypoglycemic agents in rats Journal of Pharmacology and Experimental Therapeutics 258(1): 8-12
Muller, A.J. 1972: Lactic acidosis and bone marrow suppression due to oral hypoglycemic agents Journal of the American Osteopathic Association 71(12): 1093-1097
Chuang, L.M.; Lu, C.; Su, R.J.; Wu, H.P.; Tai, T.Y.; Lin, B.J. 1992: Bedtime intermediate-acting insulin in the treatment of secondary failure to oral hypoglycemic agents Journal of the Formosan Medical Association 91(2): 185-189
Aftab, M.T.; Dharamshi, H.A.; Faraz, A.; Shakeel, S.; Shakeel, O. 2017: Poor adherence with ACE inhibitors is a risk factor of CVA with oral hypoglycemic agents in diabetic patients Pakistan Journal of Pharmaceutical Sciences 30(2): 415-419
Colman, P.G.; Harrison, L.C.; Tait, B.D. 1985: Insulin secretion and immuno-genetic markers in diabetics with 'secondary failure' of oral hypoglycemic agents Australian and New Zealand Journal of Medicine 15(2): 209-212
Hazard, J. 1976: Hypoglycemic complications induced by hypoglycemic sulfonamides. Recall of pharmacological basis of their therapeutic use La Nouvelle Presse Medicale 5(14): 903-905
Vu, T.Quoc. 2019: Hypoglyceamia cases in diabetic patients with insulin and oral hypoglycemic agents: A retrospective research in a secondary health facility Jpma. Journal of the Pakistan Medical Association 69(Suppl. 2)(6): S75-S79
Zubchenko, V.G.; Kulik, M.I. 1973: Synthesis of azolidine derivatives with possible hypoglycemic action. IX. 2'-Arylsulfonyl-3-aryl-(alkyl-) derivatives of 2-iminothiazolidone-4 Farmatsevtychnyi Zhurnal 28(5): 28-33
Accettella, U.; Sacra, A.; Gentile, M. 1970: Hypoglycemic attacks caused by oral hypoglycemic drugs Il Policlinico. Sezione Pratica 77(37): 1173-1178
Ruiz, F.; Durruty, P.; López, G.; García de los Ríos, M. 1981: Insulin levels in non-insulin dependent diabetics with secondary failure to oral hypoglycemic agents Revista Medica de Chile 109(9): 821-824
Unger, J. 2010: Choosing among the incretin agents and why it matters Journal of Family Practice 59(5 Suppl): S30-S35
Goranov, I.; Naumova, R.; Kerekovska, M.; Balabanski, L. 1987: Indications for and the therapeutic action of hypolipidemic agents in patients with hyperlipoproteinemias Vutreshni Bolesti 26(1): 96-101
Scheen, A.J.; Radermecker, R.P.; Philips, J.C.; Paquot, N. 2007: Incretin mimetics and incretin enhancers for the treatment of type 2 diabetes Revue Medicale Suisse 3(122): 1884; 1886-1888